Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer.
(Q34658204)
scientific article
scientific article
Language:
Current Data About
Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer.
other details
description | scientific article |
External Links
(P356) |
10.1038/BJC.2014.401
|
(P698) |
25117816
|
(P932) |
4260019
|
(P5875) |
264707799
|
(P6179) |
1038064509
|
(P8608) |
release_uplowblyyzfrboschwj7y4lx3y
|